Pharmacological interventions to manage coronary heart disease.
The white paper, Saving Lives: Our Healthier Nation (Department of Health, 1999), set a target to reduce the death rate from heart disease by 40 per cent for people aged under 75 by 2010. To meet this, the National Service Framework for Coronary Heart Disease (DoH, 2000) set out a plan to ensure agreed standards of care are available to everyone. One focus is to prevent illness through secondary prevention.
Parkinson
Denis
D
University of Salford, Manchester.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors